Opko health, inc. (OPK)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Total revenues

211,466

224,344

228,772

226,368

222,451

221,852

249,815

263,685

254,914

160,983

246,040

292,601

266,382

171,322

298,035

357,100

291,037

276,191

143,034

42,429

30,084

25,533

19,773

23,545

22,274

20,692

20,641

23,821

31,376

16,261

11,795

10,211

8,777

5,794

6,807

8,428

6,950

5,678

7,455

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

47

-

-

-

-

Costs and expenses:
Gross margin, excluding amortization of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,790

-

2,790

3,538

2,772

2,330

2,605

Selling, general and administrative

76,132

79,130

80,542

88,475

95,158

95,103

84,071

87,653

91,519

95,928

103,177

105,579

109,944

36,974

124,845

117,511

128,001

102,947

55,246

20,937

17,446

15,244

14,010

14,874

13,812

15,445

13,572

13,879

12,424

10,367

7,322

5,435

4,671

5,066

4,348

4,700

5,055

4,440

5,644

Research and development

21,760

23,038

30,017

28,286

36,529

33,328

30,160

29,211

32,887

34,242

32,508

33,128

26,557

30,277

24,424

31,348

27,822

25,478

18,937

29,570

25,503

25,826

20,517

16,234

20,994

23,350

11,085

9,557

9,910

6,578

3,621

4,490

4,831

4,255

3,301

2,708

1,088

1,543

1,575

In-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

10,055

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration

-860

-14,776

-1,109

-3,775

4,806

-4,410

1,193

-15,358

1,759

1,053

-11,213

4,366

2,371

1,350

3,093

10,758

1,753

-1,422

1,636

-339

5,175

368

19,592

1,876

2,610

2,774

252

2,577

1,344

-1,880

556

965

1,144

-

-

-

-

-

-

Amortization of Intangible Assets

14,900

15,369

16,412

16,419

16,600

16,474

16,899

17,227

17,300

17,595

18,023

17,953

17,929

17,063

18,116

15,778

13,443

13,966

8,110

3,236

2,665

2,614

2,735

2,826

2,744

2,941

2,790

2,688

2,714

2,058

2,178

2,108

1,991

789

945

905

765

568

913

Asset impairment charges

0

91,745

0

0

655

21,778

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grant repayment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

25,889

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total costs and expenses

252,228

336,807

267,783

273,628

297,769

311,866

283,279

268,793

297,525

318,614

293,805

318,432

311,597

244,998

321,658

328,834

318,555

284,126

151,257

67,838

86,998

57,985

67,974

58,430

52,551

56,558

39,651

41,804

38,149

30,960

21,164

19,552

12,637

27,353

8,594

8,313

6,908

6,551

8,132

Operating Income (Loss)

-40,762

-112,463

-39,011

-47,260

-75,318

-90,014

-33,464

-5,108

-42,611

-157,631

-47,765

-25,831

-45,215

-73,676

-23,623

28,266

-27,518

-7,935

-8,223

-25,409

-56,914

-32,452

-48,201

-34,885

-30,277

-35,866

-19,010

-17,983

-6,773

-9,712

-9,369

-9,341

-8,847

-8,474

-5,804

-4,775

-4,136

-4,221

-5,527

Other income and (expense), net:
Interest income

142

232

350

572

556

1,131

43

27

39

-24

249

136

249

137

163

135

43

229

13

5

8

322

402

7

40

139

88

90

59

65

49

47

27

113

159

8

8

-

-

Interest expense

5,496

5,468

5,792

5,501

4,755

3,957

2,944

2,722

2,267

1,830

1,840

1,502

1,429

1,408

2,018

2,217

1,787

2,123

2,745

986

2,565

1,690

2,402

4,685

3,486

3,654

3,409

3,842

2,897

430

393

231

351

1,633

-456

-259

87

-

-

Fair value changes of derivative instruments, net

621

168

-21

-388

415

-446

-155

2,248

1,396

-1,917

-7,550

5,482

4,037

8,667

-5,701

1,235

-1,423

-4,983

32,244

-16,556

-49,788

-14,531

3,305

10,967

-10,373

-7,251

-27,793

12,651

-23,549

-91

169

23

1,117

-

-

-

-

-

-

Other income (expense), net

-12,332

9,086

-15,470

-5,874

977

-8,118

-824

8,584

1,893

7,351

597

-533

3,042

359

-2,972

5,970

546

-9,004

17,482

760

-1,508

-4,989

-2,764

2,990

1,675

32,211

-7,787

8,027

2,331

194

55

-266

181

469

-671

-129

43

-320

-390

Other income and (expense), net

-17,065

4,018

-20,933

-11,191

-2,807

-11,390

-3,880

8,137

1,061

3,580

-8,544

3,583

5,899

7,755

-10,528

5,123

-2,621

-15,881

46,994

-16,777

-53,853

-20,888

-1,459

9,279

-12,144

21,445

-38,901

16,926

-24,056

-262

-120

-427

974

-914

-374

122

122

-

-

Loss before income taxes and investment losses

-57,827

-108,445

-59,944

-58,451

-78,125

-101,404

-37,344

3,029

-41,550

-154,051

-56,309

-22,248

-39,316

-65,921

-34,151

33,389

-30,139

-23,816

38,771

-42,186

-110,767

-53,340

-49,660

-25,606

-42,421

-14,421

-57,911

-1,057

-30,829

-9,974

-9,489

-9,768

-7,873

-8,761

-6,475

-4,904

-4,093

-4,541

-5,917

Income tax provision

1,171

3,424

1,769

1,084

783

-28,288

-11,563

2,017

-892

61,164

-24,405

-10,960

-6,944

-31,489

-19,988

15,868

-20,506

-26,457

-92,978

251

5,509

-985

294

101

614

-586

1,290

925

43

-9,715

-128

2

215

-19,556

-27

-8

233

83

54

Net loss before investment losses

-58,998

-111,869

-61,713

-59,535

-78,908

-73,116

-25,781

1,012

-40,658

-215,215

-31,904

-11,288

-32,372

-34,432

-14,163

17,521

-9,633

2,641

131,749

-42,437

-116,276

-52,355

-49,954

-25,707

-43,035

-13,835

-59,201

-1,982

-30,872

-

-9,361

-

-

-

-

-

-

-

-

Loss from investments in investees

-134

-481

-294

-271

-1,854

-2,954

-1,874

-7,213

-2,456

-2,699

-4,013

-5,628

-2,131

-2,505

-814

-1,988

-2,345

-1,038

-3,502

-804

-1,761

-1,101

-60

-370

-2,056

-3,595

-1,600

-2,371

-3,890

-596

-468

-475

-523

-414

-301

-451

-423

-208

-244

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,749

-5,347

-4,749

-4,832

-

Income from discontinued operations, net of tax

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

183

-

-

8,022

-1,487

-399

-955

-2,522

-

Loss before investment losses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9,770

-8,088

-

-6,448

-4,896

-4,326

-4,624

-5,971

Net loss

-59,132

-

-62,007

-59,806

-80,762

-

-27,655

-6,201

-43,114

-

-35,917

-16,916

-34,503

-36,937

-14,977

15,533

-11,978

1,603

128,247

-43,241

-118,037

-53,456

-50,014

-26,077

-45,091

-

-60,801

-

-

-1,038

-9,646

-10,245

-8,611

-

-

-

-

-

-

Loss per share, basic and diluted:
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-60,801

-4,353

-34,762

-

-9,829

-

-

-

-

-

-

-

-

Less: Net loss attributable to noncontrolling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-475

-925

-490

-1,345

-597

-540

-630

-803

-959

-547

-

0

0

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-16,800

-59,998

-3,394

-34,215

-546

-9,646

-10,245

-8,611

18,403

-8,236

-5,746

-5,704

-7,354

-6,215

Preferred stock dividend

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

420

560

560

560

560

519

600

615

645

656

661

Net loss attributable to common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,603

128,247

-42,766

-117,112

-52,966

-48,669

-25,480

-44,551

-16,800

-59,998

-3,394

-34,635

-1,106

-10,206

-10,805

-9,171

17,884

-8,836

-6,361

-6,349

-8,010

-6,876

Loss per share basic and diluted:
Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.02

-

-

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-

Loss per share (in dollars per share)

-0.09

-0.18

-0.11

-0.10

-0.14

-0.13

-0.05

-0.01

-0.08

-0.40

-0.06

-0.03

-0.06

-0.07

-0.03

0.03

-0.02

0.03

0.26

-0.09

-0.26

-0.13

-0.11

-0.06

-0.11

-0.03

-0.17

-0.01

-0.11

-0.01

-0.03

-0.04

-0.03

0.06

-0.03

-0.02

-0.02

-0.03

-0.03

Loss from continuing operations, per basic and diluted share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.17

-

-

-

-0.03

-

-

-

-0.02

-0.02

-

-0.02

-

Income from discontinued operations, per basic and diluted share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-

-

0.00

-

-

-

-0.01

0.00

-

-

-

Weighted average common shares outstanding, basic and diluted (in shares)

640,578

622,771

586,351

586,351

586,344

573,773

559,786

559,541

559,473

-

559,405

-

558,434

-

552,229

-

545,823

-

-

-

446,480

-

-

413,339

412,909

410,079

360,638

336,732

312,932

289,516

298,103

297,836

297,543

-

285,582

285,135

-

255,252

255,252

Earnings Per Share, Diluted

-

-

-

-

-

-

-

-

-

-

-

-0.04

-

-

-

0.02

-

-

0.18

-0.09

-

-

-0.11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding, basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

559,348

-

-

-

547,558

-

-

500,562

462,253

-

-

427,577

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding, diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

564,163

-

-

-

557,040

-

-

515,512

462,253

-

-

427,577

-

-

-

-

-

-

-

-

-

-

-

-

-

261,042

-

-

Services
Total revenues

170,839

177,946

181,139

178,458

178,891

183,067

202,811

216,055

211,315

119,377

200,876

233,912

228,545

151,013

259,025

266,012

252,522

221,843

103,919

1,908

2,069

2,061

2,482

2,153

1,970

2,608

2,770

3,188

3,092

1,417

100

145

87

-

-

-

-

-

-

Cost of service revenue

122,887

124,877

126,348

130,078

129,903

135,458

137,347

134,408

139,441

139,883

135,203

143,901

139,966

146,981

138,554

140,971

137,597

131,871

56,670

2,505

2,259

-17,943

2,359

12,565

12,391

-26,393

11,952

13,103

11,757

8,850

7,487

6,554

4,987

4,158

4,017

4,890

4,178

3,348

4,850

Products
Total revenues

31,074

32,042

26,161

28,680

25,301

25,343

25,395

28,523

27,851

33,767

22,795

28,966

22,231

20,192

20,569

22,807

19,899

21,047

20,765

22,848

15,486

18,472

17,291

21,392

19,828

17,453

16,563

18,618

15,527

15,244

11,495

9,917

8,639

5,706

6,760

8,428

6,950

5,678

7,455

Cost of service revenue

17,371

17,404

15,573

14,145

14,156

14,073

13,609

15,652

14,648

16,735

16,107

13,505

14,830

12,346

12,626

12,468

9,939

11,286

10,658

11,929

8,061

-

8,761

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Transfer Of Intellectual Property And Other [Member]
Total revenues

9,553

14,356

21,472

19,230

18,259

13,442

21,609

19,107

15,748

7,839

22,369

29,723

15,606

117

18,441

68,281

18,616

33,301

18,350

17,673

12,529

5,000

0

0

476

631

1,308

2,015

12,757

-400

200

149

51

-

-

-

-

-

-